Article info

Extended report
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial

Authors

  1. Correspondence to Dr Alf Kastbom, Department of Rheumatology, IKE, Pathology building, floor 10, Linköping University Hospital, Linköping SE 581 85, Sweden; alf.kastbom{at}liu.se
View Full Text

Citation

Kastbom A, Forslind K, Ernestam S, et al
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial

Publication history

  • Received April 8, 2014
  • Revised October 31, 2014
  • Accepted November 7, 2014
  • First published December 30, 2014.
Online issue publication 
January 11, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.